Scarica l'app Stockscreener
2.36
7.45%
-0.19
Precedente Chiudi:
$2.55
Aprire:
$2.53
Volume 24 ore:
116.38K
Relative Volume:
0.49
Capitalizzazione di mercato:
$56.52M
Reddito:
$48.20M
Utile/perdita netta:
$-35.05M
Rapporto P/E:
-1.5058
EPS:
-1.5673
Flusso di cassa netto:
$-13.02M
1 W Prestazione:
-38.70%
1M Prestazione:
-25.32%
6M Prestazione:
+118.52%
1 anno Prestazione:
-13.24%
Intervallo 1D:
$2.321
$2.55
Intervallo di 1 settimana:
$2.225
$4.00
Portata 52W:
$1.06
$5.22
Celularity Inc Stock (CELU) Company Profile
Nome
Celularity Inc
Settore
Industria
Telefono
(908) 768-2170
Indirizzo
170 PARK AVE, FLORHAM PARK
Confronta CELU con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
CELU
Celularity Inc
|
2.36 | 61.07M | 48.20M | -35.05M | -13.02M | -1.5673 |
|
VRTX
Vertex Pharmaceuticals Inc
|
396.93 | 102.81B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
453.54 | 58.59B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
567.22 | 61.25B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
733.66 | 43.23B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
318.73 | 36.53B | 3.81B | -644.79M | -669.77M | -6.24 |
Celularity Inc Stock (CELU) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2023-01-30 | Downgrade | Morgan Stanley | Equal-Weight → Underweight |
| 2022-12-22 | Downgrade | Oppenheimer | Outperform → Perform |
| 2022-06-22 | Iniziato | H.C. Wainwright | Buy |
| 2022-04-06 | Downgrade | Truist | Buy → Hold |
| 2022-01-28 | Iniziato | Oppenheimer | Outperform |
| 2021-11-24 | Iniziato | Morgan Stanley | Equal-Weight |
Mostra tutto
Celularity Inc Borsa (CELU) Ultime notizie
Celularity Inc. Equity Warrant stock trend outlook and recovery path2025 Performance Recap & Real-Time Volume Analysis - Newser
Chart based analysis of Celularity Inc. trendsWeekly Trend Report & Low Drawdown Investment Strategies - Newser
Multi asset correlation models including Celularity Inc.2025 Pullback Review & Expert Approved Momentum Ideas - Newser
What is the long term forecast for Celularity Inc. Equity Warrant stock2025 Investor Takeaways & Capital Protection Trading Alerts - khodrobank.com
What earnings revisions data tells us about Celularity Inc. Equity Warrant2025 Trading Recap & AI Enhanced Trading Signals - Newser
Celularity Achieves Nasdaq Compliance with Recent Filing - The Globe and Mail
Published on: 2025-09-04 05:10:48 - Newser
Celularity Inc. Equity Warrant stock trend forecastTrade Exit Report & Fast Exit Strategy with Risk Control - Newser
What makes Celularity Inc. Equity Warrant stock price move sharply2025 Price Momentum & Free Expert Approved Momentum Trade Ideas - Newser
Real time scanner hits for Celularity Inc. explainedAnalyst Downgrade & Weekly High Momentum Picks - Newser
Celularity Fulfills Nasdaq Listing Rule, Retires $41.6mln Debt, and Unveils Growth Plans - AInvest
Is it time to cut losses on Celularity Inc. Equity WarrantShare Buyback & Daily Volume Surge Trade Alerts - Newser
Can machine learning forecast Celularity Inc. recoveryShort Setup & Capital Efficient Trade Techniques - Newser
Is Celularity Inc. being accumulated by smart money2025 Big Picture & Proven Capital Preservation Methods - khodrobank.com
Will Celularity Inc. Equity Warrant see short term momentumBuy Signal & Community Verified Trade Alerts - Newser
Can Celularity Inc. continue delivering strong returns2025 Analyst Calls & Verified Momentum Watchlists - khodrobank.com
Using data filters to optimize entry into Celularity Inc.Earnings Growth Report & Low Drawdown Investment Ideas - Newser
Using AI based signals to follow Celularity Inc.2025 Market Overview & Verified Swing Trading Watchlists - Newser
Order flow analysis tools used on Celularity Inc.CPI Data & Fast Gaining Stock Strategy Reports - Newser
Sentiment Recap: Can Celularity Inc. Equity Warrant outperform under higher oil pricesPortfolio Value Report & Reliable Breakout Stock Forecasts - khodrobank.com
Celularity Announces Filing of Form 10-Q Quarterly Reports for the First Quarter and the Second Quarter 2025, Confirmation of Nasdaq Listing Rule 5250(c)(1) Compliance - Stock Titan
Celularity Files Q1 and Q2 2025 Form 10-Q Reports, Confirms Nasdaq Listing Rule Compliance - AInvest
Celularity Announces Filing of Form 10-Q Quarterly Reports - GlobeNewswire
Celularity Reports Q1 and Q2 Earnings, Complies with Nasdaq Listing Rules. - AInvest
Real time social sentiment graph for Celularity Inc.Earnings Trend Report & Safe Capital Allocation Plans - Newser
Analyzing recovery setups for Celularity Inc. investorsMarket Trend Summary & Reliable Entry Point Trade Alerts - Newser
Risk vs reward if holding onto Celularity Inc. Equity WarrantPortfolio Profit Report & Fast Gain Swing Alerts - Newser
What recovery options are there for Celularity Inc.Analyst Downgrade & Free Long-Term Investment Growth Plans - Newser
Is Celularity Inc. reversing from oversold territoryJuly 2025 Spike Watch & Daily Chart Pattern Signal Reports - Newser
Is a relief rally coming for Celularity Inc. Equity Warrant holdersEarnings Risk Report & Long-Term Investment Growth Plans - Newser
What’s Celularity Inc. Equity Warrant’s historical returnSwing Trade & Smart Money Movement Tracker - khodrobank.com
Celularity Inc. Building a Base Near Support getLinesFromResByArray error: size == 0 - thegnnews.com
What is the earnings history of Celularity Inc. Equity WarrantDollar Strength & High Win Rate Trade Alerts - khodrobank.com
How Celularity Inc. stock performs during market volatility2025 Pullback Review & Fast Entry High Yield Stock Tips - Newser
Real time scanner hits for Celularity Inc. Equity Warrant explainedWeekly Profit Analysis & Verified Swing Trading Watchlists - Newser
How hedge fund analytics apply to Celularity Inc. stockMarket Sentiment Report & Verified Swing Trading Watchlist - Newser
Applying chart zones and confluence areas to Celularity Inc.Weekly Profit Analysis & Growth Focused Investment Plans - Newser
Applying Wyckoff theory to Celularity Inc. stockJuly 2025 PreEarnings & Capital Efficient Trade Techniques - Newser
What moving averages say about Celularity Inc. Equity WarrantJuly 2025 Movers & Precise Swing Trade Entry Alerts - Newser
Is Celularity Inc. a strong candidate for buy and holdJuly 2025 Volume & Weekly High Return Stock Forecasts - khodrobank.com
Understanding Celularity Inc.’s price movementQuarterly Growth Report & Free Expert Verified Stock Movement Alerts - Newser
Has Celularity Inc. found a price floor2025 AllTime Highs & Daily Volume Surge Trade Alerts - Newser
Using Ichimoku Cloud for Celularity Inc. Equity Warrant technicalsMarket Trend Review & High Conviction Buy Zone Picks - Newser
Celularity Inc. shares drop 40.36% intraday after reporting a 53% decline in Q2 revenue and a 278% increase in net loss. - AInvest
Nasdaq Down 1%; Signet Jewelers Earnings Top Views - Benzinga
What institutional flow reveals about Celularity Inc.July 2025 Rallies & Low Drawdown Investment Strategies - Newser
Is Celularity Inc. stock a top performer YTD2025 Market WrapUp & Verified Momentum Watchlists - khodrobank.com
Combining price and volume data for Celularity Inc. Equity WarrantMarket Growth Report & Reliable Price Action Trade Plans - Newser
Statistical indicators supporting Celularity Inc. Equity Warrant’s strength2025 Earnings Surprises & Daily Stock Trend Reports - Newser
Can volume confirm reversal in Celularity Inc. Equity WarrantJuly 2025 Gainers & Stepwise Trade Signal Implementation - Newser
Is Celularity Inc. stock a good dividend stockJuly 2025 Market Mood & Fast Gain Stock Tips - khodrobank.com
Celularity Inc Azioni (CELU) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Celularity Inc Azioni (CELU) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Hariri Robert J | Chief Executive Officer |
Apr 13 '25 |
Option Exercise |
0.00 |
3,281 |
0 |
21,482 |
| Haines John R | Senior Exec Vice President |
Apr 13 '25 |
Option Exercise |
0.00 |
1,641 |
0 |
29,698 |
| Beers David C | Chief Financial Officer |
Apr 13 '25 |
Option Exercise |
0.00 |
1,025 |
0 |
18,561 |
| Brigido Stephen | Pres., Functional Regeneration |
Feb 17 '25 |
Option Exercise |
0.00 |
10,000 |
0 |
11,641 |
| Beers David C | Chief Financial Officer |
Feb 17 '25 |
Option Exercise |
0.00 |
12,500 |
0 |
21,932 |
| Haines John R | Senior Exec Vice President |
Feb 17 '25 |
Option Exercise |
0.00 |
20,000 |
0 |
35,092 |
1.75%
1.11%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):